IONQ Inc vs Mesoblast Limited — how do they compare? IONQ Inc trades at $36.17 (market cap $12.78B), while Mesoblast Limited trades at $16.38 (market cap $2.17B). The key difference: IONQ Inc is far larger — about 5.9× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals.
| IONQ | MESO | |
|---|---|---|
Market Cap | $12.78B | $2.17B |
Sector | Technology | Technology |
52-Week High | $82.09 | $20.96 |
52-Week Low | $26.59 | $12.88 |
Enterprise Value | $10.78B | $2.17B |
Trailing returns across standard periods
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →